Loading …
Skip to content
BioBuzz BioBuzz

Biotech and Life Science News, Jobs, and Events for the BioHealth Capital Region

Primary Menu
  • News
    • BioHealth Capital Region News
    • Philadelphia Biotech News
  • Jobs
    • Biomanufacturing Jobs in Maryland
  • Employment Resources
    • Career Resources
    • Employer Resources
  • Events
    • Free Event Listing
  • People
    • 5 Questions With…
    • In Conversation
    • People On The Move
    • Submit Your People On The Move
  • About
    • Create More Buzz
  • Join the Community
    • Create Account
    • Login

Merck to Acquire Maryland-based OncoImmune’s Promising COVID-19 Drug in $425 Million Deal

Published on : November 23, 2020November 23, 2020 Published by : Chris Frew

Merck to Acquire Maryland-based OncoImmune’s Promising COVID-19 Drug in $425 Million Deal

Tagged in : Acquisition COVID-19 Merck OncoImmune
Categorized in : BioHealth Capital Region News Featured

Stay in the Loop!

* indicates required
View All Jobs Post a Job

Categories

Past Newsletter Issues

Annual Sponsors

 

American Gene Technologies

Bio-Trac

CRB

Frederick Department of Economic Development

Lab Owl Bioreactor Control System

 

 

  • Online Community
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • Youtube

Made with ♥ in Baltimore

Terms & Conditions  Privacy Policy

© 2021 BioBuzz Media™